Canada Markets close in 5 hrs 33 mins
  • S&P/TSX

    18,412.57
    -71.96 (-0.39%)
     
  • S&P 500

    3,903.34
    -22.09 (-0.56%)
     
  • DOW

    31,886.46
    -75.40 (-0.24%)
     
  • CAD/USD

    0.8003
    +0.0014 (+0.1745%)
     
  • CRUDE OIL

    62.98
    -0.24 (-0.38%)
     
  • BTC-CAD

    64,098.93
    +1,834.82 (+2.95%)
     
  • CMC Crypto 200

    1,025.66
    +31.00 (+3.12%)
     
  • GOLD FUTURES

    1,773.20
    -24.70 (-1.37%)
     
  • RUSSELL 2000

    2,271.10
    -13.28 (-0.58%)
     
  • 10-Yr Bond

    1.4600
    +0.0710 (+5.11%)
     
  • NASDAQ

    13,476.50
    -121.46 (-0.89%)
     
  • VOLATILITY

    23.17
    +1.83 (+8.58%)
     
  • FTSE

    6,670.49
    +11.52 (+0.17%)
     
  • NIKKEI 225

    30,168.27
    +496.57 (+1.67%)
     
  • CAD/EUR

    0.6540
    -0.0026 (-0.40%)
     

WHO panel to issue recommendations on Moderna vaccine next week

·1 min read
Moderna's logo is reflected in a drop on a syringe needle in this illustration

GENEVA (Reuters) - An independent panel of vaccine experts has reviewed data from Moderna Inc's COVID-19 vaccine and will make public its recommendations on the vaccine's use next Tuesday, the World Health Organization (WHO) said on Friday.

In an advisory to media about next week, the WHO said on Friday night: "The Strategic Advisory Group of Experts (SAGE) on Immunization will make public its interim recommendations to WHO on the use of Moderna COVID-19 (mRNA-1273) vaccine. The recommendations have been agreed at the SAGE extraordinary meeting held on 21 January (Thursday)."

Mariangela Simao, WHO assistant director-general for access to medicines, vaccines and pharmaceuticals, speaking to a WHO social media event on Wednesday, noted that the SAGE experts had issued recommendations for the use of the Pfizer vaccine in early January. "It is already meeting for another vaccine quite soon," Simao said.

(Reporting by Stephanie Nebehay; Editing by Leslie Adler)